Inventor · disambiguated record
Adam Yeager
Also filed as: YEAGER ADAM · YEAGER ADAM R · YEAGER ADAM RICHARD
32 granted patents·15 pending applications·106 citations·filing 2010–2024
96Inventor score
Files withESCIENT PHARMACEUTICALS INC21RECEPTOS INC13CELGENE INT II SARL4CELGENE INT II SÀRL4BOEHM MARCUS F3
Top patents by PatentIndex Score
47 records- 0194US11919864B2Modulators of Mas-related G-protein receptor X2 and related products and methodsESCIENT PHARMACEUTICALS INC·Filed 2021·Granted Mar 5, 2024·3 cites·52 claims
- 0294US11667636B2Modulators of Mas-related G-protein receptor X2 and related products and methodsESCIENT PHARMACEUTICALS INC·Filed 2021·Granted Jun 6, 2023·3 cites·32 claims
- 0389US11952346B2Modulators of mas-related G-protein receptor X2 and related products and methodsESCIENT PHARMACEUTICALS INC·Filed 2021·Granted Apr 9, 2024·1 cites·11 claims
- 0489US10259823B2GLP-1 receptor modulatorsCELGENE INT II SARL·Filed 2017·Granted Apr 16, 2019·7 cites·26 claims
- 0589US9388147B2Selective sphingosine 1 phosphate receptor modulators and methods of chiral synthesisRECEPTOS INC·Filed 2015·Granted Jul 12, 2016·9 cites·36 claims
- 0688US11970452B2Modulators of mas-related G-protein receptor X2 and related products and methodsESCIENT PHARMACEUTICALS INC·Filed 2021·Granted Apr 30, 2024·1 cites·4 claims
- 0788US8362048B2Selective sphingosine 1 phosphate receptor modulators and methods of chiral synthesisRECEPTOS INC·Filed 2010·Granted Jan 29, 2013·10 cites·24 claims
- 0887US9839664B2GLP-1 receptor modulatorsCELGENE INT II SÀRL·Filed 2016·Granted Dec 12, 2017·8 cites·34 claims
- 0987US8778923B2GLP-1 receptor modulatorsRECEPTOS INC·Filed 2012·Granted Jul 15, 2014·11 cites·12 claims
- 1086US9474755B2GLP-1 receptor modulatorsRECEPTOS INC·Filed 2015·Granted Oct 25, 2016·6 cites·80 claims
- 1186US9260427B2GLP-1 receptor modulatorsRECEPTOS INC·Filed 2014·Granted Feb 16, 2016·8 cites·57 claims
- 1285US12129243B2Modulators of Mas-related G-protein receptor X2 and related products and methodsESCIENT PHARMACEUTICALS INC·Filed 2023·Granted Oct 29, 2024·0 cites·11 claims
- 1385US9278910B2GLP-1 receptor stabilizers and modulatorsBOEHM MARCUS F·Filed 2012·Granted Mar 8, 2016·9 cites·8 claims
- 1485US9187522B2GLP-1 receptor modulatorsRECEPTOS INC·Filed 2014·Granted Nov 17, 2015·7 cites·16 claims
- 1584US12129244B2Modulators of Mas-related G-protein receptor X2 and related products and methodsESCIENT PHARMACEUTICALS INC·Filed 2023·Granted Oct 29, 2024·0 cites·36 claims
- 1684US9700543B2GLP-1 receptor stabilizers and modulatorsCELGENE INT II SÀRL·Filed 2016·Granted Jul 11, 2017·5 cites·8 claims
- 1784US8357706B2Sphingosine 1 phosphate receptor modulators and methods of chiral synthesisRECEPTOS INC·Filed 2010·Granted Jan 22, 2013·6 cites·31 claims
- 1884US2025026735A1Modulators of mas-related g-protein receptor x2 and related products and methodsESCIENT PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 1982US11040954B1CXCR3 receptor agonistsRECEPTOS LLC·Filed 2020·Granted Jun 22, 2021·2 cites·36 claims
- 2081US12384748B2Modulators of mas-related g-protein receptor X2 and related products and methodsESCIENT PHARMACEUTICALS INC·Filed 2024·Granted Aug 12, 2025·0 cites·10 claims
- 2181US8507538B2Selective heterocyclic sphingosine 1 phosphate receptor modulatorsBOEHM MARCUS F·Filed 2010·Granted Aug 13, 2013·5 cites·59 claims
- 2281US2025289815A1Modulators of mas-related g-protein receptor x2 and related products and methodsESCIENT PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 2380US10239846B2Selective sphingosine 1 phosphate receptor modulators and methods of chiral synthesisCELGENE INT II SARL·Filed 2017·Granted Mar 26, 2019·2 cites·10 claims
- 2480US2024300907A1Modulators of mas-related g-protein receptor x4 and related products and methodsESCIENT PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 2580US2024059667A1Modulators of mas-related g-protein receptor x2 and related products and methodsESCIENT PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 2676US12275707B2Modulators of mas-related g-protein receptor X2 and related products and methodsESCIENT PHARMACEUTICALS INC·Filed 2023·Granted Apr 15, 2025·0 cites·42 claims
- 2776US12240845B2Modulators of mas-related G-protein receptor X2 and related products and methodsESCIENT PHARMACEUTICALS INC·Filed 2023·Granted Mar 4, 2025·0 cites·41 claims
- 2876US11840521B2Modulators of Mas-related G-protein receptor X4 and related products and methodsESCIENT PHARMACEUTICALS INC·Filed 2022·Granted Dec 12, 2023·0 cites·32 claims
- 2974US2024239749A1Modulators of mas-related g-protein receptor x2 and related products and methodsESCIENT PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 3073US11643399B2Modulators of mas-related G-protein receptor X4 and related products and methodsESCIENT PHARMACEUTICALS INC·Filed 2021·Granted May 9, 2023·0 cites·23 claims
- 3173US10034886B2GLP-1 receptor modulatorsCELGENE INT II SARL·Filed 2017·Granted Jul 31, 2018·1 cites·14 claims
- 3271US9598430B2GLP-1 receptor modulatorsRECEPTOS INC·Filed 2015·Granted Mar 21, 2017·1 cites·56 claims
- 3369US9795613B2GLP-1 receptor modulatorsCELGENE INT II SÀRL·Filed 2015·Granted Oct 24, 2017·1 cites·13 claims
- 3467US2025170141A1Mrgprx2 modulators and related methods of treatmentESCIENT PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 3565US2024246980A1Modulators of mas-related g-protein receptor d and related products and methodsESCIENT PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 3665US2021032213A1Modulators of mas-related g-protein receptor x4 and related products and methodsESCIENT PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 3759US2015252037A1Selective heterocyclic sphingosine 1 phosphate receptor modulatorsRECEPTOS INC·Filed 2014·Application pending·0 cites
- 3858US11787767B2Modulators of mas-related g-protein receptor X4 and related products and methodsESCIENT PHARMACEUTICALS INC·Filed 2021·Granted Oct 17, 2023·0 cites·8 claims
- 3957US2013231326A1Selective sphingosine 1 phosphate receptor modulators and methods of chiral synthesisRECEPTOS INC·Filed 2013·Application pending·0 cites
- 4056US2014039183A1Selective heterocyclic sphingosine 1 phosphate receptor modulatorsRECEPTOS INC·Filed 2013·Application pending·0 cites
- 4156US2024254089A1Modulators of mas-related g-protein receptor x4 and related products and methodsESCIENT PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 4255US2013196966A1Sphingosine 1 phosphate receptor modulators and methods of chiral synthesisRECEPTOS INC·Filed 2013·Application pending·0 cites
- 4353US2017165236A1Selective sphingosine 1 phosphate receptor modulators and combination therapy therewithCELGENE INT II SÀRL·Filed 2014·Application pending·0 cites
- 4448US9394264B2Sphingosine 1 phosphate receptor modulators and methods of chiral synthesisRECEPTOS INC·Filed 2015·Granted Jul 19, 2016·0 cites·36 claims
- 4541US9481659B2Selective heterocyclic sphingosine 1 phosphate receptor modulatorsBOEHM MARCUS F·Filed 2012·Granted Nov 1, 2016·0 cites·31 claims
- 4639US2019345133A1Cxcr3 receptor agonistsCELGENE INT II SARL·Filed 2017·Application pending·0 cites
- 4736US11530205B2GLP-1 receptor modulatorsRECEPTOS LLC·Filed 2018·Granted Dec 20, 2022·0 cites·18 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →